As the progression of coronary artery disease is the manifestation of a cluster of several risk factors, the impact of A-FABP on the development of atherosclerosis would be reduced in subjects of advanced age; thus, the impact of increased plasma A-FABP can be regarded as a coronary risk factor especially in patients aged < 65 years. Here, FABP4 is linked to atherosclerosis.